Evidence Reviews
Literature reviews organized by indication, Cochrane-adjacent synthesis.
This hub is built as a directory: 2 topics, each with its head profile and the supporting posts nested beneath it. Every post opens with the Evidence Ledger, never a dosing prescription.
Cochrane-adjacent literature synthesis by indication, inclusion criteria, effect sizes, limitations, our assessment.
- Topics
- 2
- Posts live
- 12
Sorted by topic.
Each profile opens with the Evidence Ledger; the supporting posts beneath it cover side effects, reported doses, and related questions.
Peptides for Weight Loss: What Actually Works
One peptide class genuinely drives weight loss in trials. The rest, sold as fat-loss peptides in the research-chemical channel, range from weakly supported to abandoned. An honest map of both.
Read the profileSupporting posts land here as they clear editorial review. The profile is the place to start.
Peptides for Muscle Growth: The Evidence, Graded
Growth-hormone secretagogues, IGF-1 peptides and collagen all get sold for muscle. What the human trials actually show, why GH peptides disappoint lifters, and the legal options that beat all of them.
Read the profileSupporting posts land here as they clear editorial review. The profile is the place to start.
Side by side, by evidence tier.
GHK-Cu Topical vs Injection: Where the Evidence Sits
GHK-Cu topical versus injection on the evidence: why nearly all the human-relevant data is topical, why injectable use has no trial and raises copper-safety questions, and how to read the two routes honestly.
BPC-157 and TB-500 Together: What the Evidence Actually Shows
The BPC-157 and TB-500 combination, often marketed as a recovery stack, on the evidence: what each compound does in animal models, why no human trial has tested the pair, and what the enthusiasm rests on.
The terms and mechanisms underneath.
- Explainer7 min
GHK-Cu Before and After: What to Expect From the Evidence
GHK-Cu before-and-after on the evidence: what the skin and hair studies actually measured, why online transformation photos are not trial data, and a realistic view of the timeframes and magnitudes involved.
- Explainer9 min
Peptides for Healing: What the Evidence Actually Supports
Peptides for healing on the evidence: which repair-associated peptides have human data, which rest on animal wound-healing models, and why the strongest healing peptide is one most people already know.
- Explainer12 min
BPC-157 for Tendon Repair, Literature Review
Inclusion criteria, 8-10 preclinical studies tabulated, the human evidence gap, and an honest assessment of the tendon claims.
- Explainer10 min
GHK-Cu for Hair, What the Evidence Supports
GHK-Cu and copper peptides for hair reviewed honestly: the in-vitro dermal-papilla data, the absence of a completed human hair-loss trial, and how to read the topical serum claims against the science.
- Explainer11 min
BPC-157 for Gut Health: The Evidence
BPC-157 for the gut, weighed against the evidence: strong animal data for ulcer, fistula and colitis healing, and why published human proof is still missing.
- Explainer11 min
Peptides for Sleep: What the Evidence Shows
Peptides for sleep weighed against the evidence: why DSIP's human data is old and thin, what the orexin system really shows, and why the marketing outruns the trials.
- Explainer8 min
TB-500 for Recovery: A Literature Review
TB-500 for recovery on the evidence: the animal wound-healing and cardiac-repair data behind thymosin beta-4, the single completed human trial in a different tissue, and why athletic-recovery claims remain unproven.
Literature syntheses by indication.
Get the 2026 Peptide Evidence Ledger.
A 12-page PDF summary of where 10 major compounds sit, Preclinical / Human pilot / Phase trial / FDA status. Updated quarterly. Free.
By subscribing, you agree to our Privacy Policy. One calm, cited email a week. Unsubscribe anytime.